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   ABSTRACT 
 
Spondyloepiphyseal dysplasia tarda (SEDT), an X-linked genetic disease manifesting 
itself in a disproportionate skeletal structure, is caused by mutations in the SEDL gene. 
Four missense mutations (S73L, V130D, F83S, and D47Y) have been identified by 
molecular diagnosis as disease-causing SEDT. Nevertheless, how SEDL mutations 
disrupt the skeletal structure and cause disease remains unknown. We report here the 
cloning, expression, and characterization of three different missense mutations (S73L, 
V130D, and D47Y) in mouse SEDL. The overexpression of the D47Y mutation was 
mainly observed in the supernatant but those of the S73L and V130D mutations are 
shown in the insoluble pellets. The substitution of the S73L mutation induces the 
exposure to hydrophobic amino acids and causes aggregation. That of V130D might 
break hydrophobic interaction and decrease the secondary structure. The CD spectra of 
three mutants (S73L, V130D, and D47Y) showed that the α-helices decreased more 
than that of wild-type SEDL. The F83S (stop) mutant might suggest a large 
conformational change as the mutant V130D. In order to visualize conformational 
changes in mutated structures, we used molecular modeling techniques minimizing the 
total energy. These results could provide the biological characterization and 
conformational information of the SEDL mutants and suggest the clinical severity of the 
disorder among human SEDL patients. 
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INTRODUCTION 
 
The X-linked form of SEDT, a 
radiologically distinct skeletal dysplasia 
affecting the vertebrae and epiphyses, is 
caused by mutations in the SEDL gene. 
This progressive skeletal disorder, which 
manifests itself in childhood, is 
characterized by disproportionately short 
stature with short neck and trunk, barrel 
chest, and the absence of systemic 
complications (Bannerman et al. 1971, 
Iceton et al. 1986, MacKenzie et al. 1996). 
SEDL is widely expressed in tissues 
including fibroblasts, lymphoblasts and 
fetal cartilage (MacKenzie et al. 1996). 
The SEDL gene in Xp22 is composed of 
six exons and spans a genomic region of 
approximately 20 kb. It encodes a protein 
of 140 amino acids and plays a role in 
vesicular transport from the ER to the 
Golgi complex (Gedeon et al. 1999, 
Sacher et al. 2001). The recent finding that 
a defect in the protein sedlin, whose yeast 
counterpart is involved in the first step of 
the secretory pathway, leads to a cartilage-
specific disorder in humans, raises 
numerous questions and interesting 
possibilities for understanding both the 
pathobiology involved and the role of 
membrane trafficking in normal cartilage 
development (Sacher 2003). 
 
Different mutations in patients have been 
identified along the entire length of the 
SEDL ORF (420-bp open reading frame); 
these include nonsense mutations, 
missense mutations, deletions, insertions, 
and splicing errors (Shi et al. 2002, 
Fiedler et al. 2002, Shaw et al. 2003, Xiao 
et al. 2003, Shaw et al. 2004, Fiedler et al. 
2004, Bar-Ysef et al. 2004). The 
pathogenetic consequences of SEDL 
mutations are still mostly unknown on the 
molecular level. Recently, the crystal 
structure of a 2.4 Å resolution mouse 
SEDL was isolated by X-ray analysis 
(Jang et al. 2002). In that structure, three 
residues (S73, V130, and F83) were 
buried with low solvent accessibility and 
located at structurally important sites 
where the mutations would disrupt the 
structure. The D47 residue was exposed 
on the surface of the protein, which area is 
the major area of interactions with a 
partner protein (Fig. 1). SEDL mutations 
can perturb an intracellular pathway that is 
important in cartilage homeostasis. 
However, how those replacements of each 
of the four amino acids in wild-type SEDL 
disrupt functional interaction is still 
unknown. 
 
We report here the sub-cloning, 
expression, purification, CD analysis, and 
modeling of SEDL mutations. This 
information could allow the biological 
characterization of the SEDL mutations 
and suggest the clinical severity of the 
disorder among human SEDL patients.
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Figure 1: The stereoview of the ribbon diagram of the SEDL monomer 
The four side chains of missense mutations are represented by ball and stick, 
respectively. The SEDL monomer adopts a mixed three α–helices / five β-
sheets topology with the β–sheets (shown in magenta) surrounded by the α–
helices (shown in yellow). 
 
Materials and Methods 
 
Site-specific mutagenesis 
The full-length encoded mSEDL gene 
(140 amino-acids) was amplified from a 
mouse cDNA library using the 
polymerase chain reaction (PCR) 
technique. The PCR products were 
purified, digested with XhoI and BlpI, and 
then ligated into the pET15b vector 
(Novagen). The three SEDL mutations 
selected for the present study consisted of 
three missense mutations, C218T (S73L), 
T389A (V130D), and G139T (D47Y). 
Site-specific mutagenesis was performed 
using a Quickchange site-directed 
mutagenesis kit (Stratagene). The stop 
codon in the F83S mutation was created at 
the primer for the sub-cloning. The S73L, 
V130D, and D47Y mutants were 
amplified with forward and reverse 
oligonucleotide primers from the 
recombinant pET15b vector/SEDL 
plasmid, respectively, using the PCR 
technique. For S73L, the forward primer 
was 5’-CGCTCGAGATGTCTGGGAGC 
TTCTACTTTGTAAT- 3’, and the reverse 
primer was 5’-GGAATTCGCTGAGCCT 
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AGCTTAAAAGGTGTTTCTTCCC-3’. 
For V130D, the forward primer was 5’-
TCGACAGGAAAGACCAGTTTCTTGG
-3’, and the reverse primer was 5’-
CCAAGAAACTGGTCTTTCCTGTCGA
-3’.For D47Y, the forward primer was 5’-
ATGCTGCTCTTTTACCTTGTGGACG
A-3’, and the reverse primer was 5’–
TCGTCCACAAGGTAAAGAGCAGCAT
–3’. The PCR amplifications were 
performed using a procedure of 16 cycles 
of reaction with denaturing at 95 oC for 30 
sec, annealing at 55 oC for 1 min, and 
extension at 68 oC for 6 min. The 4,400 bp 
band was generated from PCR product 
using 1% agarose gel electrophoresis. 
After the PCR, the amplified DNA 
fragments were ligated by T4 DNA ligase. 
The ligation mixture was used to 
transform competent cells of E. coli XL1-
blue. The colonies were isolated, and the 
plasmids were obtained using Qiagen 
miniprep kits. All of the DNA sequences 
of the mutated genes were verified by 
sequencing. 
 
Expression and purification 
Mouse SEDL was expressed in the 
Escherichia coli strain BL21(DE3)RIL 
and purified as previously described (Jang 
et al. 2002b). The cells were initially 
grown in 50 mL of LB-ampicillin (50 
μg/ml) and chloramphenicol (170 μg/ml) 
overnight at 37 oC. Inoculars were added 
to 2 L of LB-ampicillin and 
chloramphenicol. The large cultures were 
immediately moved to an incubator and 
stored at 37 oC. When the culture reached 
an A600 of 0.5-0.7, isopropyl β-D-
thiogalactopyranoside (IPTG) was added 
at a final concentration of 1 mM to induce 
6x His-tagged SEDL mutants as well as 
wild-type SEDL. After 4-6 h, the cells 
were harvested and D47Y was lysed by 
sonication in an equilibrium buffer (50 
mM Tris-HCl [pH 7.5] and 200 mM 
NaCl). The supernatant of the D47Y 
SEDL was used for purification, but for 
the S73L and V130D mutations, insoluble 
pellets were used. Inclusion bodies of the 
S73L and V130D were obtained by 
sonication and resuspended in a buffer (25 
mM Tris-HCl [pH 8.0], 100 mM NaCl, 
and 1 mM DTT) containing 6 M urea. 
Each inclusion body solution was added to 
a refolding solution (100 mM NaCl, 25 
mM Tris-HCl [pH 8.0], and 1 mM DTT). 
The wild-type SEDL and its three 
mutations were purified as an (His)6-
tagged fusion protein at the N terminus 
and obtained after cleavage by thrombin 
(Figure 2b). All of the purifications 
required the nickel-nitriltriacetic acid (Ni-
NTA) column (Qiagen), the Resource Q 
anion exchange column (Amersham 
Biosciences), and the Superdex 75 column 
(Amersham Biosciences). The purity of 
the purified SEDL was determined by 
sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) with 4% 
(w/v) stacking and 12% (w/v) resolving 
gels, as described by Laemmli. The 
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protein solutions were concentrated to 5- 10 mg/ml using a Vivaspin 20 (Satorius). 
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Figure 2: SDS-PAGE analysis of the SEDL mutant expressed in E. coli 
a) Lanes 1 and 2, supernatants of lysed bacteria of D47Y SEDL before and 
after induction by IPTG, respectively; Lane 3, molecular weight markers b) 
Cleavage test of the His-tagged D47Y SEDL. Lane 1, markers; Lanes 2 and 3, 
D47Y SEDL (18 KDa) before and after His-tag cleavage (16 KDa, 6 mg/ml), 
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respectively c) Lanes 1 and 2, S73L supernatants before and after induction, 
respectively; Lanes 3 and 4, S73L pellets before and after induction, 
respectively; Lane 5, markers d) Lanes 1 and 2, V130D supernatants before 
and after induction, respectively; Lanes 3 and 4, V130D pellets before and after 
induction, respectively; Lane 5, markers e) Lanes 1 and 2, refolded S73L (3 
mg/ml) and V130D (4mg/ ml) mutants, respectively; Lane 3, markers f) 
concentrated wild-type SEDL protein (14 mg/ml) 
 
MALDI-TOF analysis 
For in-gel digestion, 10 ul of trypsin 
solution (2 ng/L in 25 mM of ammonium 
bicarbonate [pH 8.0]) was added and 
digested at 37 oC overnight. Peptides were 
extracted with 50% ACN/0.2% TFA 
(trifluoroacetic acid) and dried under 
vacuum for 2 h, followed by 
reconstruction with 3 ul of CHCA (α-
cyano-4-hydroxycinnamic acid) matrix 
solution (8 mg of CHCA in 1 ml of 50% 
ACN/0.2% TFA; Gharahdaghi et al. 1999). 
One microliter of reconstructed sample 
was loaded on a 96×2 MALDI plate. The 
peptide mass was acquired with the 
Voyager DE-PRO (Applied Biosystems, 
Framingham, MA) in a reflector mode 
under 20,000 V of accelerating voltage, 
76% grid voltage, and 0.002% guide-wire 
voltage. Cal Mix 2, of the MALDI-MS 
calibration kit (Applied Biosystems, 
Framingham, MA), was used for the 
external calibration, and autolysis 
fragments of trypsin were used for the 
internal calibration. Peptide matching and 
protein searches were performed with the 
Mascot peptide mass fingerprint (Fig. 3). 
 
Far-UV CD spectroscopy analysis 
Circular Dichroism (CD) spectroscopy 
was used to identify how much the 
secondary structure was affected by the 
replacement of three amino acids in wild-
type SEDL. The CD spectra of the 
purified wild-type and mutant proteins 
were measured from 200 to 260 nm using 
a 0.05 cm pathlength cell at ambient 
temperature and a JASCO J-715 
spectropolarimeter. Each spectrum was 
the average of five scans. Far-UV CD 
spectra were taken at the protein 
concentration of 0.5 mg/ml. The CD 
spectra were obtained in milli-degrees and 
converted to molar ellipticity prior to the 
secondary structure analysis. The far-UV 
CD spectra of the mutant and native 
proteins are shown in Figure 4. 
 
Molecular modeling 
The models of the four different missense 
mutations (S73L, V130D, F83S, and 
D47Y) in mouse SEDL were constructed 
using O program (Jones et al. 1991). 
Refinement to minimize the total energy 
of the models was performed with the 
CNS package (Brunger et al. 1998). The 
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root mean square deviation (rmsd) 
differences from ideal geometries for bond 
lengths and angles were calculated with 
CNS. The overall stereochemical quality 
of the final models for the mutations of 
SEDL were assessed by the program 
PROCHECK (Laskowski et al. 1993). 
 
 
 
Figure 3: MALDI-TOF mass spectrum analysis 
MALDI-TOF peptide spectrum of mouse D47Y SEDL 
 
RESULTS AND DISCUSSION 
 
SEDL appears to be an evolutionarily 
conserved protein, as its homologues have 
been identified in mice and humans 
(Gedeon et al. 1999). SEDT is caused by 
production of a probable nonfunctional 
form of SEDL caused by mutations in the 
SEDL gene located at human 
chromosome Xp22. Four different 
missense mutations in SEDL, S73L, 
V130D, F83S, and D47Y, are responsible 
for SEDT. Those four mutations are 
completely conserved in mice and humans. 
Recently, the SEDL protein crystal 
structure has been determined and 
confirmed sites of four different mutations 
(Fig. 1; Jang et al. 2002a). Nevertheless, 
the function of SEDL and its role in bone 
metabolism remains unknown. Also, how 
SEDL mutations cause the rare 
osteochondrodysplasia is not known. 
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Several methods to predict the structure 
and function of proteins have suggested a 
significant change (Grunebaum et al. 
2001). 
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Figure 4: Circular dichroism spectra of SEDL and its variants 
The CD spectra were measured from 260 to 200 nm using a 0.05 pathlength 
cell and the CD signals were merged to CDNN. The color scheme includes wild-
type SEDL represented in black, S73L in blue, V130D in green, and D47Y in red. 
 
To study the physiological functions of 
mutant SEDL, the wild-type and mutated 
SEDL genes of mice were constructed and 
expressed in E coli. The pET-15b vector 
was used in the expression of His-tagged 
fusion SEDL constructs at the N terminus. 
The constructs were transformed into the 
expression host E. coli BL21(DE3)RIL, 
and the protein expressions were induced 
by 1 mM of IPTG. An SDS-PAGE 
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analysis of the SEDL mutations is shown 
in Figure 2. We found that there were 
different effects of the mutations on 
protein expression and protein solubility. 
The expression of the D47Y protein was 
clearly shown in the supernatant but those 
of the S73L and V130D proteins were 
mainly observed in the insoluble pellets 
(Figs. 2a, c and d). The expressions of the 
S73L and V130D mutations showed a 
marked decrease by aggregation in an 
SDS-PAGE analysis. Inclusion bodies of 
the S73L and V130D mutations were 
refolded and purified. 
 
MALDI-TOF study of D47Y mutant 
revealed the approximate molecular mass 
of the recombinant protein, which was in 
accordance with the theoretical mass 
prediction for the SEDL protein with the 
peptide mass tolerance (50 ppm). Mass-
fingerprinting analysis of the proteins 
were carried out by subjecting them to 
trypsin digestion. The monoisotopic 
masses obtained for the individual 
peptides were in the range of 800-3,000 
Da. The sequences of the digested 
peptides were matched (masses matched 
No. 6/44, molecular weight 16440.9 Da, 
accession No. Q9CQP2, and pI 6.02) with 
the protein sequences in the database 
using the PROFOUND program. The 
spectra of the peptide masses obtained for 
SEDL are shown in Figure 3. The result 
showed that molecular weight of the 
mutated D47Y SEDL was almost identical 
to that of the wild-type protein, by 
ultracentrifugation analysis, of 16205.3 
Da. An ultracentrifugation analysis further 
evidenced the monomerization of SEDL 
in solution (data not shown). 
 
To investigate the effect of mutations on 
the structural integrity of the SEDL 
protein, CD spectra were obtained for 
each mutant as well as for wild-type 
SEDL. The CD spectra of the SEDL 
mutants showed that each mutation 
affected the conformation of SEDL to a 
different extent (Fig. 4). The three 
mutations (S73L, V130D, and D47Y) 
induced significant structural changes 
compared with the wild-type. The CD 
spectrum of the wild-type SEDL exhibited 
a negative maximum at about 208 nm and 
a broad shoulder peak at about 222 nm, 
which is a typical pattern of α-helix 
protein. The CD spectrum of the purified 
S73L exhibited only a negative peak at 
217 nm. The mutant S73L maintained the 
α–helices except α4 disruption and 
interacted with water molecules (S13). 
The β–strands pattern of the S73L was 
different from the case of V130D and 
D47Y by CD spectra. The V130D 
mutation had significantly unfolded in the 
α-helices regions (α2 and α3), and the β–
strands and random coils were increased 
(Table 1). The CD spectral shape of D47Y, 
except for the negative peak depth, 
resembled the wild-type spectrum. The 
D47Y mutation had conformational 
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change in the longest loop region 
including the α1-helix and β3-strand 
connected at both loop termini. D47Y 
substitution induces the exposure of the 
bulky polar amino acids, removes a 
charge from a surface-exposed residue, 
and can interfere with the protein-protein 
interaction required for normal function. 
 
Table 1: The contents of the secondary structures of the wild-type and SEDL 
mutants by CD spectra 
____________________________________________________________ 
Proteins         wild-type   S73L     V130D      D47Y 
                SEDL 
____________________________________________________________ 
α-helices (%)   91.4   78.6     73.6    73.0  
β-sheets (%)   0.1   3.4    4.5     5.0  
β-turn (%)     8.4   15.8   15.7       17.3 
random coil (%) 0.1   2.2    6.2  4.7  
____________________________________________________________ 
 
The three mutants studied by CD showed 
that the secondary structure was more or 
less lost by mutation. This loss of the 
secondary structures in the proteins can be 
observed either by local structural 
perturbation or by increasing the unfolded 
fraction of a protein. However, it is not 
clear whether the structural change is 
localized around the mutation site or not. 
Several programs used to predict 
secondary protein structure, GOR IV 
(Garnier et al. 1999), HNNC (Guermeur), 
and Predator (Frishman et al. 1996), 
indicated that the F83S mutation would 
significantly alter the SEDL structure and 
introduce an additional alpha helix 
(Grunebaum et al. 2001). They suggested 
that a phenotype/genotype correlation is 
difficult to determine; however, an amino 
acid change that does not alter the rest of 
protein may not be as detrimental to the 
phenotype as a mutation that results in 
truncation of the protein. The affected 
patients in the family described there had 
very mild clinical symptoms. Contrary to 
other pedigrees with X linked SEDL, in 
which females heterozygous for the gene 
defect suffered from subtle skeletal 
abnormalities and arthritis by middle age 
(Whyte et al. 1999, Bannerman et al. 
1971), the female carriers in the family 
described here had no objective evidence 
of SEDL. This may reflect the subtle 
impact of the C→T mutation on SEDL 
protein function (Grunebaum et al. 2001). 
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Figure 5: The detailed site stereoviews of SEDL mutations. The structures of 
four molecular models were superposed with wild-type. a) The region of S73L 
b,c) The hydrophobic environment of V130D and F83S d) The region of D47Y. 
The amino acids are color-coded with C in gray, O in red, N in blue, wild-type 
(control) in yellow, and mutations in cyan. 
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To visualize the structural perturbation, 
we built models of the SEDL mutants 
(S73L, V130D, F83S, and D47Y), 
minimized the total energy of the models, 
and compared them with the wild-type 
structure (Fig. 5). The S73, V130, and F83 
residues are located at structurally 
important sites and buried in the helix-to-
helix and helix-to-strand (Fig. 1; Jang et al. 
2002a). In contrast, D47 is exposed on the 
surface, which area is the major area of 
protein-protein interaction, and which 
might be crucial to the conserved SEDL 
function. The hydroxyl group of S73 is 
involved in the hydrogen-bonding 
network, including the side chains of Y60 
and H87, the backbone nitrogen atom of 
T63, and water molecules. Replacing a 
serine with hydrophobic leucine changes 
important properties of molecules and 
produces a serial disease, because this 
residue position cannot be incorporated 
without disrupting the structure of SEDL. 
V130 and F83 are found in completely 
hydrophobic environments in the interior 
of the protein. The structural changes of 
V130D and F83S mutations probably may 
cause functional changes in the protein. 
The geometries and overall 
stereochemical quality for four mutation 
structures were generated in order to 
compare that of wild-type. The final 
models exhibited r.m.s. deviations from 
the ideal bond angles, 1.206, 1.251, 1.221, 
and 1.211 for S73L, V130D, F83S, and 
D47Y, respectively. The r.m.s. deviation 
from the ideal bond lengths was the same 
value, 0.008 for each of the four mutations. 
The structural representations are shown 
in Figure 5. Those structures have 85.7, 
85.7, 84.1, and 84.9% of amino acid 
residues for S73L, V130D, F83S, and 
D47Y in most favoured regions of a 
Ramachandran plot. The models of four 
mutations showed different geometries 
with r.m.s. deviations from wild-type. 
Also, analysis of the Ramachandran plots 
indicated that the mutation models present 
the overall stereochemical quality out of 
the residues from ideality in the most 
favored regions to compare that of wild-
type. 
 
In the case of the mutant S73L on the β4, 
a few residues around the mutation site, 
Y60, K62, T63, H87, E91 were perturbed, 
as shown in Figure 5a and Table 2. 
Whereas the interactions between β3 and 
α4 is mediated by water molecules in 
wild-type SEDL, the S73L mutation can 
break the interactions between β3 and α4 
by disrupting hydrogen bonding; it 
induces a significant structural disruption 
and the exposure of hydrophobic amino 
acids and causes aggregation. In the 
V130D mutant, a structural perturbation 
was observed in the β1 (F7), β2 (F18, 
M20), β4 (F22, F98), α2 (F98, V102, 
L105), and α3 (F126) (Fig. 5b and Table 
2). The large structural perturbations were 
mainly in helices α2 and α3. Also, we can 
guess that the F83S mutation induced a 
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significant conformational change in 
SEDL and that the structural perturbations 
were localized in the β1 (F7 and I9), β4 
(F75), α1 (T77), α2 (F99, V102, and 
Y103), and the loop (M81) (Fig. 5c). By 
contrast, the D47Y mutation between α1 
and β3 showed a large structural 
perturbation by the substitution of no 
charge and bulky amino acids. This 
indicates that a single amino acid 
substitution can break normal signal 
transduction by disrupting electrostatic 
interaction. 
 
Table 2: Selected amino acids in hydrogen bonding interactions of four mutants 
____________________________________________________________ 
Mutants  S73L    V130D  F83S   D47Y 
  (β4)   (α3)   (β5)   (loop)  
____________________________________________________________ 
   S2   F7 (β1)  F7 (β1)  I48 (loop)---α1   
  S21   F18 (β2)  I9 (β1)  V49 (loop) 
     Y60 (β3)   M20 (β2)  F75 (β4)  D50 (loop)---β3 
 K62 (β3)  F22 (β4)  T77 (α1)   
  T63 (β3)  F98 (α2)  M81 (loop) 
  H87 (β5)  V102 (α2)  F99 (α2) 
  E91 (α4)-S13  L105 (α2)  V102 (α2) 
     F126 (α3)  Y103 (α2) 
____________________________________________________________ 
The structural elements in parentheses indicate the sites of the amino acids. A 
residue name of S indicates a solvent (water) molecule. 
 
In summary, the expression levels were 
observed to determine the extent to which 
the secondary structure can be affected by 
the replacements of three each amino 
acids in the wild-type SEDL. The 
expressions of the S73L and V130D 
mutations showed a marked decrease by 
aggregation in the SDS-PAGE analysis. 
The mutants S73L and V130D could not 
obtain soluble proteins, so these proteins 
were refolded from the inclusion body. 
However, the D47Y obtain as a soluble 
protein less than wild-type. Gécz et al. 
have observed that D47Y was unable to 
complement, whereas V130D and S73L 
mutations were able to complement the 
TRS20 deletion (Gécz et al. 2003). These 
complementation results fit well with the 
different levels of our expressions in E. 
coli. The secondary structures and 
conformations of the three mutants (S73L, 
V130D, and D47Y) were significantly 
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different from those of wild-type SEDL, 
by CD spectroscopy. To study the 
multifunctional role of SEDL mutations in 
membrane trafficking, we will further 
explore the structural studies of these 
mutant proteins and their interactions. 
Characterization of the SEDL and 
determination of the SEDL mutation 
structures enable functional studies of 
SEDL and elucidation of the pathogenesis 
of SEDT. 
 
In conclusion, we have shown that the 
aggregation of S73L could be attributed to 
breakage of hydrogen bonding geometry 
and exposure to hydrophobic amino acids. 
These results indicate that the hydrogen-
bond network is important for stability 
and normal function of the protein. The 
hydrogen bonding of S73 links the two 
polar amino acids, Y60 and Q91 to S9 and 
S13 water molecules. The elimination of 
the hydroxyl group by the replacement of 
S73 with leucine results in a loss of 
conformational stability. The S73L 
mutation decreased the stability and 
soluble expression of SEDL significantly, 
and exhibited a synergistic effect on the 
aggregation of protein relative to the 
respective single mutations. Additionally, 
we suggest that S73 cannot function 
efficiently alone without additional 
support from the hydrogen bonds of Y60 
and Q91. Our results demonstrate that the 
hydrogen-bond network provides the 
structural support that is necessary for the 
protein to maintain the active-site 
geometry optimized for function and 
stability. The structural characterization of 
a SEDL protein variant with Val130 
substituted for Asp suggests that the 
variant is trapped in a conformation that 
resembles the F83S mutation by modeling 
analysis. From these results, we confirmed 
that there are no bound hydrophobic 
amino acids and that hydrophobic 
interaction was lost in the V130D and 
F83S mutant structures. Interestingly, 
although the spectral shape of the D47Y 
mutant was similar to that of the wild-type 
SEDL, the slope of the plot of D47Y was 
significantly decreased relative to that of 
the wild-type, implying that the 
environment near D47Y might cause 
conformational change by the substitution 
of the bulky amino acid and the decrease 
of interaction by the loss an amino acid 
charge. Gécz et al. identified that there is 
no obvious correlation between the nature 
and position of the SEDL mutation and 
the clinical severity of the disorder among 
the human SEDL patients (Gécz et al. 
2003). In our experiments, we have 
observed that four different mutations 
show different levels of expressions and 
characterization compared to that of wild-
type. This may reflect the subtle impact of 
the mutations on SEDL protein function 
as previously observed among SEDL 
patients. Our results suggest a difference 
in activity and/or stability of the mutant 
compared to the wild-type SEDL protein. 
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